While performing a lumpectomy, Nancy DeMore asked herself why there wasn’t an easier way to do the procedure that wouldn’t involve two invasive procedures.
MUSC is the proud home of the South Carolina Clinical and Translational Research (SCTR) Institute’s Opportunities program. The program is designed to work with industry sponsors, contract research organizations (CROs), and other potential research collaborators to pair clinical research opportunities with MUSC Investigators.
With a total 300 US and international patents award and 80 of those awarded to faculty in the last five years. MUSC is well equipped to bring ideas to practice with currently 50 active startup enterprises. MUSC startups have had products approved by the FDA, been acquired by publicly traded corporations, attracted substantial investment dollars into our state and continue to create high-paying jobs. MUSC has become a leading biomedical research institution with more than $275 million in extramural research funding in FY2018.
Our outstanding researchers seek new partners who will bring our discoveries to the marketplace. At the same time, MUSC is committed to identifying faculty experts and research technologies to assist our industry partners in developing cutting-edge solutions and strategies.
Contact the Foundation for Research Development to join your expertise with ours.